Evidence map›Paper›PMID 41209295›Full record

ReviewRSC medicinal chemistry2026

Stick to the beads: supercharging medicinal chemistry and methodology development with ChemBeads.

Noah P Tu, Ying Wang

Abstract readReview
In one paragraph

Review in RSC medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Noah P TuAbbVie Inc. 1 N. Waukegan Rd North Chicago Illinois 60064 USA noahtu@hotmail.com.ORCID https://orcid.org/0000-0002-9164-3815
Ying WangAbbVie Inc. 1 N. Waukegan Rd North Chicago Illinois 60064 USA noahtu@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This perspective explores the development, preparation, and widespread application of ChemBeads, a solid reagent delivery platform designed to overcome longstanding challenges in miniaturized and automated chemical experimentation. Originating from innovation at AbbVie, ChemBeads are formed by dry-coating active reagents onto inert carrier beads, transforming poorly flowing powders into uniform, flowable materials compatible with robotic and manual dispensing. Enabled by resonant acoustic mixing (RAM) or alternative techniques like vortex mixing, ChemBeads have streamlined high-throughput experimentation (HTE) and medicinal chemistry workflows. Their applications span a wide range of transformations including photoredox catalysis, cross-electrophile coupling, C-N and C-H functionalizations and late-stage oxidations. Industrial and academic case studies highlight the critical role of ChemBeads in accelerating the development of new synthetic methodologies that would have otherwise taken significantly longer to accomplish. By solving the long standing problem of material handling at a miniaturized scale with efficiency and generality, ChemBead technology formed the foundation of the AbbVie Discovery HTE platform and positioned us as one of the industry leaders in this field. Over the years, we expanded the technology to make it greatly accessible to academic institutions by making the process economically and operationally friendly. In parallel, we extended this technology in other areas, which ultimately promoted industry-academia collaborations. The technology's expansion into biocatalysis (EnzyBeads), solubility assays, and solid form screening further demonstrates its adaptability.

Identifiers

PMID41209295
PMCPMC12590957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.